AbCellera Biologics Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
AbCellera Biologics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • AbCellera Biologics Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $14.8M, a 15.1% decline year-over-year.
  • AbCellera Biologics Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $65M, a 1.76% decline year-over-year.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2024 was $67.6M, a 5.29% increase from 2023.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $64.2M, a 29.7% increase from 2022.
  • AbCellera Biologics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $49.5M, a 61.5% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $67.6M +$3.4M +5.29% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $64.2M +$14.7M +29.7% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $49.5M +$18.8M +61.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $30.6M +$22.2M +265% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 $8.4M +$7.51M +843% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $890K Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.